Latest news

Thumbnail image for GSK, MMV submit malaria drug in the US

GSK, MMV submit malaria drug in the US

GlaxoSmithKline and the Medicines for Malaria Venture are seeking permission to market single-dose tafenoquine in the US to prevent relapse of Plasmodium vivax malaria.

30th November 2017

Thumbnail image for Stellar results for Novartis, Teva anti-CGRP migraine drugs

Stellar results for Novartis, Teva anti-CGRP migraine drugs

The New England Journal of Medicine has published two separate studies showing that CGRP-targeting therapies – namely Novartis' erenumab and Teva’s fremanezumab - significantly cut the number of headache days in patients with episodic or chronic migraine, respectively.

30th November 2017

Thumbnail image for Avelumab fails to improve survival in gastric cancer

Avelumab fails to improve survival in gastric cancer

Merck and Pfizer have revealed that a Phase III trial assessing avelumab in patients with gastric cancer after two prior therapeutic regimens failed to hit its primary target of showing an improvement in survival.

29th November 2017

Thumbnail image for NICE issues guidelines on asthma

NICE issues guidelines on asthma

The National Institute for Health and Care Excellence has published new guidelines designed to improve the diagnosis and management of asthma.

29th November 2017

Thumbnail image for Regeneron calls time on Eylea/nesvacumab combo

Regeneron calls time on Eylea/nesvacumab combo

Regeneron says that a combination of Eylea and nesvacumab being co-developed with Bayer will not move into Phase III testing for two eye conditions following disappointing Phase II data.

28th November 2017

Thumbnail image for ViiV trials long-acting, two-drug HIV regimen

ViiV trials long-acting, two-drug HIV regimen

ViiV Healthcare has kicked off a late-stage study testing a long-acting, two-drug regimen of its cabotegravir and Janssen’s rilpivirine in virally suppressed adults with HIV-1 infection

28th November 2017

Thumbnail image for AZ forms new company in China

AZ forms new company in China

AstraZeneca has entered into a strategic joint venture with the Chinese Future Industry Investment Fund (FIIF) to form an equally-owned, stand-alone company in China.

28th November 2017

Thumbnail image for UK Gov publishes Industrial Strategy

UK Gov publishes Industrial Strategy

The government is calling two major new investments in the UK by pharma firms a “huge vote of confidence” in its approach to industrial strategy.

27th November 2017

Thumbnail image for GSK to use Owlstone’s breath biopsy in COPD trial

GSK to use Owlstone’s breath biopsy in COPD trial

In a major boon for UK diagnostics group Owlstone Medical, GlaxoSmithKline is incorporating the firm’s Breath Biopsy platform into the clinical development programme for its novel, experimental respiratory drug danirixin.

27th November 2017

Previous  --   6 7 8 9 10 11 12 13 14 15   --  Next

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download